We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Walmart, NVIDIA, Procter & Gamble, Phillips 66 and AstraZeneca
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 21, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Walmart (WMT - Free Report) , NVIDIA (NVDA - Free Report) , Procter & Gamble (PG - Free Report) , Phillips 66 (PSX - Free Report) and AstraZeneca (AZN - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports on Walmart, nVIDIA and Procter & Gamble
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT - Free Report) , NVIDIA (NVDA - Free Report) and Procter & Gamble (PG - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Buy-rated Walmart’s shares have been strong performers lately, with the stock up +24.1% over the last six months, outperforming the S&P 500's +7.8% gain in the same time period. The Zacks analyst likes Walmart’s solid earnings and comps record. The company has been gaining from constant e-commerce initiatives, like buyouts, alliances, and improved delivery systems.
These trends, along with solid traffic drove Walmart’s third-quarter fiscal 2018 performance, wherein both earnings and revenues rose year over year and beat estimates. Notably, this marked Walmart’s ninth and 13th straight quarter of positive earnings surprise and U.S. comps growth, respectively.
Also, the company’s international performance gained from strength in food categories. All these factors encouraged management to raise its view. However, stiff competition from brick and mortar and online retailers remains a concern. Also, macroeconomic woes like volatile consumer spending poses threats.
Shares of Strong Buy-rated NVIDIA have surged over the last year, gaining in excess of +127.4% versus the Zacks Semiconductor - General industry’s +52% gain. NVIDIA posted impressive third-quarter fiscal 2018 results and provided encouraging fourth quarter revenue guidance.
Also, the company registered year-over-year growth on both counts, primarily due to growth across all its four platforms. Better-than-expected demand for gaming chips helped the company post encouraging results.
The Zacks analyst likes NVIDIA’s sustained efforts toward attaining robust position in several emerging industries such as Artificial Intelligence (AI), deep learning and driverless cars. NVIDIA’s innovative product pipeline and strength in gaming and high-end notebook GPUs remain the positives. The company’s focus on GRID platforms can increase GPU adoption in data centers, giving it an advantage against its competitors.
Procter & Gamble's shares have underperformed the Zacks Soap and Cleaning Materials industry so far this year (+5.2% vs. +14.2%). P&G reported first-quarter fiscal 2018 results, wherein earnings and revenues surpassed expectations. Adjusted earnings increased 6% from the year-ago level aided by productivity cost savings.
Overall organic sales were up 1%, comprising 1% volume growth despite decelerating market growth and a 30 bps headwind from natural disasters. The Zacks analyst likes the company’s focus on balanced growth through improved product, packaging, and marketing initiatives and its productivity cost saving plan.
However, core gross and operating margin weakness was notable in the quarter that decreased 40 bps each. Lower pricing, higher commodity costs, increased competition and an unfavorable mix continued to hurt profitability. Again, decelerating organic sales growth in developed and developing markets raise concerns.
Other noteworthy reports we are featuring today include Phillips 66 and AstraZeneca.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Walmart, NVIDIA, Procter & Gamble, Phillips 66 and AstraZeneca
For Immediate Release
Chicago, IL – November 21, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Walmart (WMT - Free Report) , NVIDIA (NVDA - Free Report) , Procter & Gamble (PG - Free Report) , Phillips 66 (PSX - Free Report) and AstraZeneca (AZN - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports on Walmart, nVIDIA and Procter & Gamble
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT - Free Report) , NVIDIA (NVDA - Free Report) and Procter & Gamble (PG - Free Report) . These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Buy-rated Walmart’s shares have been strong performers lately, with the stock up +24.1% over the last six months, outperforming the S&P 500's +7.8% gain in the same time period. The Zacks analyst likes Walmart’s solid earnings and comps record. The company has been gaining from constant e-commerce initiatives, like buyouts, alliances, and improved delivery systems.
These trends, along with solid traffic drove Walmart’s third-quarter fiscal 2018 performance, wherein both earnings and revenues rose year over year and beat estimates. Notably, this marked Walmart’s ninth and 13th straight quarter of positive earnings surprise and U.S. comps growth, respectively.
Also, the company’s international performance gained from strength in food categories. All these factors encouraged management to raise its view. However, stiff competition from brick and mortar and online retailers remains a concern. Also, macroeconomic woes like volatile consumer spending poses threats.
(You can read the full research report on Walmart here >>>).
Shares of Strong Buy-rated NVIDIA have surged over the last year, gaining in excess of +127.4% versus the Zacks Semiconductor - General industry’s +52% gain. NVIDIA posted impressive third-quarter fiscal 2018 results and provided encouraging fourth quarter revenue guidance.
Also, the company registered year-over-year growth on both counts, primarily due to growth across all its four platforms. Better-than-expected demand for gaming chips helped the company post encouraging results.
The Zacks analyst likes NVIDIA’s sustained efforts toward attaining robust position in several emerging industries such as Artificial Intelligence (AI), deep learning and driverless cars. NVIDIA’s innovative product pipeline and strength in gaming and high-end notebook GPUs remain the positives. The company’s focus on GRID platforms can increase GPU adoption in data centers, giving it an advantage against its competitors.
(You can read the full research report on NVIDIA here >>>).
Procter & Gamble's shares have underperformed the Zacks Soap and Cleaning Materials industry so far this year (+5.2% vs. +14.2%). P&G reported first-quarter fiscal 2018 results, wherein earnings and revenues surpassed expectations. Adjusted earnings increased 6% from the year-ago level aided by productivity cost savings.
Overall organic sales were up 1%, comprising 1% volume growth despite decelerating market growth and a 30 bps headwind from natural disasters. The Zacks analyst likes the company’s focus on balanced growth through improved product, packaging, and marketing initiatives and its productivity cost saving plan.
However, core gross and operating margin weakness was notable in the quarter that decreased 40 bps each. Lower pricing, higher commodity costs, increased competition and an unfavorable mix continued to hurt profitability. Again, decelerating organic sales growth in developed and developing markets raise concerns.
(You can read the full research report on Procter & Gamble here >>>).
Other noteworthy reports we are featuring today include Phillips 66 and AstraZeneca.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.